BACKGROUND: Studies have demonstrated a higher rate of nodal metastases in melanoma of childhood, but there is controversy about the overall prognosis relative to adults. We describe a large single-institution experience with pediatric melanoma and assess prognostic characteristics. METHODS: Retrospective review identified 126 patients diagnosed with melanoma at <21 years of age and referred for treatment from 1986 to 2011. Atypical lesions were excluded. Clinicopathologic characteristics were correlated with sentinel lymph node (SLN) status and outcomes. RESULTS: SLN biopsy was positive in 18 of 62 cases (29 %). Increasing Breslow thickness correlated with a positive SLN (p < 0.05). After a median follow-up of 5 years, there were 27 recurrences and 20 deaths. Positive SLN patients had significantly worse recurrence-free survival (RFS, p < 0.05) and significantly worse melanoma-specific survival (MSS, p = 0.05) compared with negative SLN patients. The 5-year RFS and MSS for positive SLN patients were 59.5 and 77.8 %, compared with 93.7 and 96.8 % for negative SLN patients. Recurrences and melanoma-related deaths were often seen beyond 5 years. No deaths have occurred in patients <12 years, but 9.1 % of patients 12-17 years and 17.2 % of patients 18-20 years died from melanoma (p = 0.291). CONCLUSIONS: Children with melanoma have higher rates of SLN metastases (29 %) than adults with comparable melanomas. Despite the higher incidence of nodal metastases, survival is equal to or better than what is reported for adults. However, long-term follow-up is necessary in this population since recurrences and deaths are often seen beyond 5 years.
BACKGROUND: Studies have demonstrated a higher rate of nodal metastases in melanoma of childhood, but there is controversy about the overall prognosis relative to adults. We describe a large single-institution experience with pediatric melanoma and assess prognostic characteristics. METHODS: Retrospective review identified 126 patients diagnosed with melanoma at <21 years of age and referred for treatment from 1986 to 2011. Atypical lesions were excluded. Clinicopathologic characteristics were correlated with sentinel lymph node (SLN) status and outcomes. RESULTS: SLN biopsy was positive in 18 of 62 cases (29 %). Increasing Breslow thickness correlated with a positive SLN (p < 0.05). After a median follow-up of 5 years, there were 27 recurrences and 20 deaths. Positive SLN patients had significantly worse recurrence-free survival (RFS, p < 0.05) and significantly worse melanoma-specific survival (MSS, p = 0.05) compared with negative SLN patients. The 5-year RFS and MSS for positive SLN patients were 59.5 and 77.8 %, compared with 93.7 and 96.8 % for negative SLN patients. Recurrences and melanoma-related deaths were often seen beyond 5 years. No deaths have occurred in patients <12 years, but 9.1 % of patients 12-17 years and 17.2 % of patients 18-20 years died from melanoma (p = 0.291). CONCLUSIONS:Children with melanoma have higher rates of SLN metastases (29 %) than adults with comparable melanomas. Despite the higher incidence of nodal metastases, survival is equal to or better than what is reported for adults. However, long-term follow-up is necessary in this population since recurrences and deaths are often seen beyond 5 years.
Authors: Sabela Paradela; Eduardo Fonseca; Salvador Pita-Fernández; Sara M Kantrow; Abdul H Diwan; Cynthia Herzog; Victor G Prieto Journal: Cancer Date: 2010-09-15 Impact factor: 6.860
Authors: Jennifer H Aldrink; M Angelica Selim; Diana L Diesen; Jeffrey Johnson; Scott K Pruitt; Douglas S Tyler; Hilliard F Seigler Journal: J Pediatr Surg Date: 2009-08 Impact factor: 2.545
Authors: Robert Howman-Giles; Helen M Shaw; Richard A Scolyer; Rajmohan Murali; James Wilmott; Stanley W McCarthy; Roger F Uren; John F Thompson Journal: Ann Surg Oncol Date: 2009-08-12 Impact factor: 5.344
Authors: Charles M Balch; Jeffrey E Gershenwald; Seng-Jaw Soong; John F Thompson; Michael B Atkins; David R Byrd; Antonio C Buzaid; Alistair J Cochran; Daniel G Coit; Shouluan Ding; Alexander M Eggermont; Keith T Flaherty; Phyllis A Gimotty; John M Kirkwood; Kelly M McMasters; Martin C Mihm; Donald L Morton; Merrick I Ross; Arthur J Sober; Vernon K Sondak Journal: J Clin Oncol Date: 2009-11-16 Impact factor: 44.544
Authors: Susan Y Euling; Marcia E Herman-Giddens; Peter A Lee; Sherry G Selevan; Anders Juul; Thorkild I A Sørensen; Leo Dunkel; John H Himes; Grete Teilmann; Shanna H Swan Journal: Pediatrics Date: 2008-02 Impact factor: 7.124
Authors: Damon Reed; Ragini Kudchadkar; Jonathan S Zager; Vernon K Sondak; Jane L Messina Journal: J Natl Compr Canc Netw Date: 2013-06-01 Impact factor: 11.908
Authors: Charles M Balch; John F Thompson; Jeffrey E Gershenwald; Seng-Jaw Soong; Shouluan Ding; Kelly M McMasters; Daniel G Coit; Alexander M M Eggermont; Phyllis A Gimotty; Timothy M Johnson; John M Kirkwood; Stanley P Leong; Merrick I Ross; David R Byrd; Alistair J Cochran; Martin C Mihm; Donald L Morton; Michael B Atkins; Keith T Flaherty; Vernon K Sondak Journal: Ann Surg Oncol Date: 2014-02-15 Impact factor: 5.344
Authors: Damon R Reed; Benjamin Oshrine; Christie Pratt; Olivia Fridgen; Cathy Elstner; Leila Wilson; Hatem Soliman; Marie C Lee; Howard L McLeod; Bijal Shah; Kristine A Donovan; Smitha Pabbathi; Mary Turney; Odion Binitie; Christine Healy; Michael Nieder; Peter H Shaw; Andrew Galligan; G Douglas Letson; Marilyn Stern; Gwendolyn P Quinn; Simon Davies Journal: J Adolesc Young Adult Oncol Date: 2017-08-04 Impact factor: 2.223
Authors: Radhika Sreeraman Kumar; Ram Thapa; Youngchul Kim; Nikhil I Khushalani; Vernon K Sondak; Damon R Reed Journal: Cancer Med Date: 2018-02-25 Impact factor: 4.452